活检证实的慢性侵袭性真菌性鼻窦炎多中心结局分析
最常见基础病为血液恶性肿瘤和糖尿病(各32%),最常见真菌为曲霉菌(63%)。1、6、12个月总生存率分别为89%、68%、48%,诊断时ANC<1000和近期化疗与较差生存相关。
要点
- 活检证实的CIFS患者1年总生存率仅48%,预后较差。
- 诊断时ANC<1000和近期化疗(1个月内)与更差生存相关。
- ANC作为连续变量升高与12个月生存改善相关。
核心结论
- 诊断时ANC<1000和近期化疗(诊断前1个月内)与更差生存相关,而ANC升高>1000与12个月生存改善相关。
主要发现
- 血液恶性肿瘤和糖尿病是最常见基础病(各32%),曲霉菌是最常见真菌(63%)。
- 超过75%的患者诊断时ANC>1000。
- 1、6、12个月总生存率分别为89%、68%、48%。
- 单因素分析中,12个月时ANC<500(HR 4.8;p=0.01)、ANC<1000(HR 5.8;p=0.001)和近期化疗(HR 4;p=0.01)与更差生存相关。
- 整个队列中ANC作为线性变量与生存改善相关(HR 0.7;p=0.005)。
临床怎么用
- 对CIFS患者应关注诊断时ANC水平和近期化疗史,用于风险分层。
- ANC<1000尤其<500提示预后较差,需加强管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic invasive fungal sinusitis (CIFS) is a rare, life-threatening infection of the nose and sinuses. This study aims to identify factors that impact survival in 1 of the largest cohorts to date. METHODS: Pathology records were reviewed for biopsy-proven CIFS from 3 tertiary academic institutions from 1995 to 2016. Variables were analyzed using log-rank survival analysis. Univariate Cox regression was performed at 1 and 12 months. RESULTS: Thirty-eight patients were included. Hematologic malignancy and diabetes were the most common underlying diseases (32% each). Aspergillus was the most common fungus (63%). Greater than 75% of the patients had an absolute neutrophil count (ANC) >1000 at the time of diagnosis. Overall survival at 1, 6, and 12 months was 89%, 68%, and 48%, respectively. In univariate analysis, factors associated with worse survival included: ANC <500 at 12 months (hazard ratio [HR] 4.8; p = 0.01), ANC <1000 at 12 months (HR 5.8; p = 0.001), and recent chemotherapy (HR 4; p = 0.01). The following factor was associated with improved survival in univariate analysis: ANC as a linear variable in the entire cohort (HR 0.7; p = 0.005). CONCLUSION: We present a multi-institutional case-series of CIFS and long-term follow-up. ANC <1000 at time of diagnosis and recent chemotherapy (within 1 month of diagnosis) are associated with poorer survival, whereas a rising ANC >1000 is associated with improved survival at 12 months. Further prospective studies are needed to further define factors that affect outcomes.
引用
- Humphreys IM, Wandell GM, Miller C, et al. A multi-institutional review of outcomes in biopsy-proven chronic invasive fungal sinusitis. Int Forum Allergy Rhinol. 2020. PMID: 32282122. doi:10.1002/alr.22547
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。